TENAYA THERAPEUTICS INC
NASDAQ: TNYA (Tenaya Therapeutics, Inc.)
最近更新时间: 昨天, 3:08AM0.679
0.01 (1.06%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Tenaya Therapeutics, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
| 分析师共识 | NA |
| 内部交易活动 | 1.5 |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -2.5 |
| 平均 | -0.13 |
|
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 0.72% |
| 机构持股比例 | 59.67% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Burkehill Global Management, Lp | 30 Jun 2026 | 2,000,000 |
| Raiffeisen Bank International Ag | 30 Jun 2026 | 1,200,000 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| ALI FARAZ | 0.649 | - | 122,000 | 79,178 |
| TINGLEY WHITTEMORE | 0.649 | - | 49,000 | 31,801 |
| 累积净数量 | 171,000 | |||
| 累积净值 ($) | 110,979 | |||
| 累积平均购买 ($) | 0.649 | |||
| 累积平均卖出 ($) | - | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| TINGLEY WHITTEMORE | 职员 | 10 Sep 2026 | 获得 (+) | 49,000 | 0.649 | 31,801 |
| ALI FARAZ | 职员 | 10 Sep 2026 | 获得 (+) | 122,000 | 0.649 | 79,178 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合